The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
The BioTechUSA group was able to grow despite market challenges
The purely domestically owned BioTechUSA group has published its annual…
Read more >May contain gluten: Aldi recalls protein bar in Hungary
Aldi Hungary has recalled a popular protein bar after it…
Read more >Sometimes we have a main meal!
Snacking is gradually losing its snacking character, turning from a…
Read more >Related news
Sustainable growth: global corrugated board market could rise to over $206 billion by 2032
The packaging industry is on the verge of a breakthrough:…
Read more >We’re not leaving the cleaning to robots for now
Price-value ratio is the most important consideration among Hungarians when…
Read more >Kifli.hu renews its premium program
Kifli.hu’s parent company, the Czech Rohlik Group, has introduced Xtra,…
Read more >